Management raised Q4 2025 revenue guidance to $21.4 million to $22.4 million and GAAP diluted EPS guidance to $0.43 to $0.47, with non-GAAP diluted EPS of $0.47 to $0.50. For full year 2025, guidance ...

Nearly 70% of patients with acute upper gastrointestinal (GI) bleeding and low-risk or no peptic ulcer disease received intravenous (IV) proton pump inhibitors (PPIs) inappropriately, leading to ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif., April 7, 2025 /PRNewswire/ -- ICU Medical Inc. (NASDAQ:ICUI), a worldwide ...

Healthcare professionals use Zyno’s Z-800, Z-800F, Z-800W and Z-800WF pumps to provide intravenous infusions of parenteral fluids, blood and blood products. The company first secured 510(k) clearance ...

TOLEDO, Ohio (WTVG) - There will be a brand new lifesaver on the roads of northwest Ohio and southeast Michigan and its goal is to save the lives of your littlest family members. On June 5, ProMedica ...

Iradimed Corporation announced that it has received FDA 510(k) clearance for its next-generation MRidium® 3870 IV Infusion Pump System, making it the only supplier of non-magnetic MRI-compatible ...

This is part one of MobiHealthNews' two-part series that will highlight the evolution of innovations that changed healthcare over the past several decades. In the past 30 years, the role of technology ...

ICU Medical Inc, a worldwide leader in the development, manufacture and sale of innovative medical devices, has announced 510(k) regulatory clearance from the US Food and Drug Administration (FDA) for ...

The provincial cancer agency is halting its use of an infusion pump line, due to concerns over leakage and heightened risk of potentially hazardous chemotherapy drug spills. *Billed as $4.00 plus GST ...

Manitoba's cancer authority has stopped using an infusion pump line — made by a company whose IV pumps have been the subject of recalls — over concerns about leakage and the increased risk of ...

Some Manitoba health facilities are still using IV pumps that have been recalled by their manufacturer. The Infusomat pumps were recalled by B Braun in June of last year, according to Health Canada.

The company provided guidance for Q1 2025, projecting revenue of $19.2M to $19.4M, GAAP diluted EPS of $0.35 to $0.39, and non-GAAP diluted EPS of $0.39 to $0.43. For FY2025, revenue is expected to ...